This week’s top stories include pipeline updates in dry eye, retinitis pigmentosa, contact lens hygiene, and more.
The meeting, which comes a year after the agency issued a complete response letter in October 2025,2 was held from 8:30 am-3 ...
The licaminlimab trial enrolled 176 patients, two-thirds with a TNFR1 variant tied to stronger response. Data expected late 2026.
Amanda Nanasy, OD, discussed how sports can open the door to eye care for underserved athletes and what goes into her performance vision evaluations. In an exclusive interview with Optometry Times, ...
FDA grants orphan drug designation to oral OCT-980 for RHO-adRP, now in phase 1b/2 testing at US sites. The FDA granted ...
Raphael Rostenne discusses what a good phone call looks like and contributes to successful patient interactions with host ...
Drs Bryce St. Clair and Behrad Garmsiri explain how they build trust, improve health literacy, and destigmatize future ...
The release noted that brepocitinib demonstrated consistent benefits in preventing treatment failure across key subgroups, ...
Open-access OCTA tools showed similar reliability, but different vessel density values in glaucoma; researchers advise using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results